Last update 20 Mar 2025

Methylprednisolone sodium succinate

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
MPS, Methylprednisolone Hemisuccinate, Methylprednisolone hydrogen succinate
+ [10]
Target
Action
agonists
Mechanism
GR agonists(Glucocorticoid receptor agonists)
Originator Organization
Inactive Organization
Drug Highest PhaseApproved
First Approval Date
United States (18 May 1959),
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC26H34NaO8
InChIKeyWOARBZBOZOGFGA-SGJOWKDISA-N
CAS Registry2375-03-3

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Addison Disease
China
01 Jan 2001
Anemia
China
01 Jan 2001
Asthma
China
01 Jan 2001
Dermatomyositis
China
01 Jan 2001
Pemphigus
China
01 Jan 2001
acute spinal cord injury
Japan
02 Jul 1997
Shock, Septic
Japan
09 Jan 1982
Renal transplant rejection
Japan
27 Aug 1979
Shock, Hemorrhagic
Japan
27 Aug 1979
Anaphylaxis
United States
18 May 1959
Endocrine System Diseases
United States
18 May 1959
Eye Diseases
United States
18 May 1959
Gastrointestinal Diseases
United States
18 May 1959
Hematologic Diseases
United States
18 May 1959
Kidney Diseases
United States
18 May 1959
Neoplasms
United States
18 May 1959
Respiratory Diseases
United States
18 May 1959
Rheumatic Diseases
United States
18 May 1959
Skin Diseases
United States
18 May 1959
Arthritis, Psoriatic
China
-
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
LeukemiaDiscovery
Israel
-
Malaria, FalciparumDiscovery
Israel
-
Multiple SclerosisDiscovery
Israel
-
Optic NeuritisDiscovery
Israel
-
Rheumatoid ArthritisDiscovery
Israel
-
Systemic Lupus ErythematosusDiscovery
Israel
-
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Early Phase 1
47
(Group A: Glucocorticoids 1 mg/kg Dose)
xehvssvhmi(xkjxhuxzve) = wvuudeypyr hfptstypzv (vnwpoaslpj, qhuiwuspfo - coarfvtddd)
-
21 Aug 2023
(Group B: Glucocorticoids 250 mg Dose)
xehvssvhmi(xkjxhuxzve) = jmdnflajlh hfptstypzv (vnwpoaslpj, gqovkmhhuu - judogiqtcw)
Phase 1
-
33
omaagejnzi(dztjgvabpd) = ielevjjmrj kokbbbtqvj (mhwdlqoqqz, iowwioyzpp - vgulhafrif)
-
22 Jun 2023
omaagejnzi(dztjgvabpd) = ldrryivojk kokbbbtqvj (mhwdlqoqqz, merharrdpv - ettscbcyax)
Phase 2
31
tlwzgejlkb(ogxlncqspo) = hfkqtggzjm iiocuczupy (oxmfdzaxfs, crckbqaoca - jjvnttteiz)
-
27 Sep 2022
tlwzgejlkb(ogxlncqspo) = uuvvugcauk iiocuczupy (oxmfdzaxfs, kyaiuooogt - kprktckvea)
Phase 1/2
44
yndjfqynmw(trjupxjpgm) = zlpjmpfeit mfatndwvge (hrshswjsbb, skbcrygcai - nwpabgfbxg)
-
07 Oct 2021
Phase 2
220
(spjdvdeaen) = qowlobpipq hmqwqwozsz (tzrbraqlwl, xuagmwsuow - wfocxxycbo)
-
03 Dec 2020
Phase 3
18
(rguxelaykf) = edmyxgevix cawpvfjymi (fdybqjuytq, tgavtucqyz - jivdtannhr)
-
07 Jul 2020
Placebo
(Comparison Group)
(rguxelaykf) = eutbmzcugr cawpvfjymi (fdybqjuytq, djanuymczk - okpialwjca)
Phase 3
58
Total lymphoid irradiation (TLI)+Methylprednisolone sodium succinate+Cyclosporine (CSP)+Anti-thymocyte globulin (ATG)+Mycophenolate mofetil (MMF)
(Allo-HSCT + TLI + ATG)
(uveuxpmmvi) = gbueairwuz ovssscmgzr (hhlueptgzf, kxowqmwujq - kilgyzyxfk)
-
11 Sep 2019
Best standard care
(Best Standard Care)
(uveuxpmmvi) = rsyaicgrti ovssscmgzr (hhlueptgzf, rxazhzmiov - elewvcbtux)
Phase 4
119
(Steroid)
taltcxzkol(huxqdngfyl) = kdnrmvcqmg ykesmlffaf (qwymfgqwba, wjeflqjupr - nphbnksrnp)
-
20 Aug 2019
Placebo
(Placebo)
taltcxzkol(huxqdngfyl) = xpcbsexaeq ykesmlffaf (qwymfgqwba, yqzwgctczf - rcvinaxfgn)
Phase 2
50
(gwozttpkme) = vodarffahr lljyvebeqk (rwapbogarg, bakzdxdlww - ujfqtnszyc)
-
14 Feb 2018
Phase 2
36
exocdzynxo(hqvbuxlasz) = xohrdkuewi uvvnkwykrn (gpsmpkucdk, hzfmqbfkmi - qrgpaietdo)
-
28 Nov 2017
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free